Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Patients must mix the powder with at least 6-8 ounces of water or a preferred beverage, and ensure they are consuming ample hydrating fluids throughout the day
UKPDS 34: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes
In a large phase 3 obesity trial (ACHIEVE-1), orforglipron at daily doses of 3, 12 and 36 mg caused approximately: Diarrhoea: 1926% of participants (vs 9% on placebo) Nausea: 1318% (vs 2% on placebo) Constipation: 817% (vs 4% on placebo) Vomiting: 514% (vs 1% on placebo) Across multiple studies, 617% of people stopped treatment because of side effects, mostly gut-related symptoms
Abdominal obesity is defined as having a waist circumference greater than 40 inches for a man or 35 inches for a woman
